Login / Signup

Treatment options in the advanced and recurrent setting for endometrial cancer: an update.

Alex Andrea FrancoeurVirginia E FontenotKrishnansu Sujata Tewari
Published in: Expert review of anticancer therapy (2024)
The treatment field is promising for patients as many of these trials appear to offer progression free and overall survival benefits in a disease with a historically poor prognosis. Molecular profiling of endometrial cancer will be the backbone of treatment paradigms in the future.
Keyphrases
  • endometrial cancer
  • poor prognosis
  • long non coding rna
  • end stage renal disease
  • newly diagnosed
  • ejection fraction